Transcription of PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION
{{id}} {{{paragraph}}}
PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION . INFORMATION . Pr VIREAD . (tenofovir disoproxil fumarate) tablets 300 mg Antiretroviral Agent Gilead Sciences, Inc. Date of Revision: May 12, 2017. Foster City, CA 94404. USA. Gilead Sciences Canada, Inc. Mississauga, ON. L5N 2W3. Submission Control No.: 201858. VIREAD (tenofovir disoproxil fumarate) tablets PRODUCT MONOGRAPH TABLE OF CONTENTS. TABLE OF CONTENTS .. 2. 1. HEALTH PROFESSIONAL INFORMATION .. 3. SUMMARY PRODUCT 3. INDICATIONS AND CLINICAL USE .. 3. CONTRAINDICATIONS .. 4. WARNINGS AND PRECAUTIONS .. 4. ADVERSE REACTIONS .. 10. DRUG INTERACTIONS .. 22. DOSAGE AND ADMINISTRATION .. 32. OVERDOSAGE .. 33. ACTION AND CLINICAL PHARMACOLOGY .. 34. STORAGE AND STABILITY .. 38. SPECIAL HANDLING INSTRUCTIONS .. 38. DOSAGE FORMS, COMPOSITION AND PACKAGING .. 38. 2. SCIENTIFIC INFORMATION .. 39. PHARMACEUTICAL INFORMATION .. 39. CLINICAL TRIALS .. 40. VIROLOGY (MICROBIOLOGY).
PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrVIREAD (tenofovir disoproxil fumarate) tablets . 300 mg . Antiretroviral Agent . Gilead Sciences, Inc.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}